⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10935463 | 1.00 | — | — | |
| SCHEMBL22689 | 0.89 | — | — | |
| Water SCHEMBL28489054 | 0.80 | — | — | |
| Potassium SCHEMBL321057 | 0.80 | — | — | |
| SCHEMBL29195976 | 0.80 | — | — | |
| Water SCHEMBL25354626 | 0.80 | — | — | |
| Phosphine SCHEMBL5852309 | 0.80 | — | — | |
| Ammonia Solution, Strong SCHEMBL2749074 | 0.80 | — | — | |
| Potassium SCHEMBL10534898 | 0.80 | — | — | |
| Ammonia Solution, Strong SCHEMBL6043 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146088-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260132220-A1 | Cysteine Engineered Antibodies and Conjugates | GENENTECH, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4727527-A2 | GRP78 TARGETED LIPOSOMAL NANOPARTICLES (TLNPS) FOR THE TREATMENT OF CANCER | University of Notre Dame du Lac (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20250388599-A1 | TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12479858-B2 | Macrocyclic compounds as sting agonists and methods and uses thereof | LUPIN LIMITED (IN) | 2025-11-25 | — | — | US | disclosed |
| EP-4622652-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER AND METABOLIC DISEASE | Pretzel Therapeutics, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024259421-A2 | GRP78 TARGETED LIPOSOMAL NANOPARTICLES (TLNPS) FOR THE TREATMENT OF CANCER | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240309088-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2024-09-19 | — | — | US | disclosed |
| EP-4427805-A2 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | Genentech, Inc. (US) | 2024-09-11 | — | — | EP | disclosed |
| EP-4004002-B1 | MACROCYCLIC COMPOUNDS AS STING AGONISTS AND METHODS AND USES THEREOF | LUPIN LTD (IN) | 2024-07-10 | — | — | EP | disclosed |
| WO-2009123971-A1 | BENZOPYRAN AND BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2009-10-08 | — | — | WO | disclosed |
| US-20090247567-A1 | BENZOPYRAN AND BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2009-10-01 | — | — | US | disclosed |
| WO-2009117277-A2 | COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE | GENENTECH, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009099728-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| WO-2009099741-A1 | NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS | GENENTECH, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| WO-2009099719-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN | GENENTECH, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| WO-2009097446-A1 | PYRAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2009-08-06 | — | — | WO | disclosed |
| US-20090068202-A1 | Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use | GENENTECH, INC. (US) | 2009-03-12 | — | — | US | disclosed |
| WO-2009012268-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2009-01-22 | — | — | WO | disclosed |
| WO-2009012256-A1 | HUMANIZED ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2009-01-22 | — | — | WO | disclosed |